CVE-2025-50675
Published Aug 7, 2025 · Updated Nov 3, 2026
Original summary
Normalized public record · Updated Nov 3, 2026
GPMAW 14, a bioinformatics software, has a critical vulnerability related to insecure file permissions in its installation directory. The directory is accessible with full read, write, and execute permissions for all users, allowing unprivileged users to manipulate files within the directory, including executable files like GPMAW3.exe, Fragment.exe, and the uninstaller GPsetup64_17028.exe. An attacker with user-level access can exploit this misconfiguration by replacing or modifying the uninstaller (GPsetup64_17028.exe) with a malicious version. While the application itself runs in the user's
Publisher and source text is retained separately from QFinch interpretation.
QFinch assessment
GPMAW 14, a bioinformatics software, has a critical vulnerability related to insecure file permissions in its installation directory. The directory is accessible with full read, write, and execute permissions for all users, allowing unprivileged users to manipulate files within the directory, including executable files like GPMAW3.exe, Fragment.exe, and the uninstaller GPsetup64_17028.exe. An attacker with user-level access can exploit this misconfiguration by replacing or modifying the uninstaller (GPsetup64_17028.exe) with a malicious version. While the application itself runs in the user's context, the uninstaller is typically executed with administrative privileges when an administrator attempts to uninstall the software. By exploiting this flaw, an attacker could gain administrative privileges and execute arbitrary code in the context of the admin, resulting in privilege escalation.
Evidence: public source recordsAffected products
| Affected package, product or range | Fix status |
|---|---|
| Consult the referenced vendor advisory for affected versions. | Consult source advisory |
Matching a version is only one part of assessing exposure. QFinch has not assessed your environment on this public page.
Remediation
Apply the vendor-supported fixed release or mitigation, then verify the affected component is no longer reachable.
- Confirm the affected product and reachable code path exist in your environment.
- Apply the vendor-supported patch or mitigation from the primary advisory.
- Rescan the exact deployed revision and retain verification evidence.
Evidence coverage
- SSVC priority
- MEDIUM
- Confidence
- Not available
- Aliases
- None reported
Scores appear only when corresponding evidence exists. Missing data is never interpreted as zero risk.
Sources and record history
Record history
Published Aug 7, 2025 · Last refreshed Nov 3, 2026